Injection, Non-Radioactive, Non-Contrast, Visualization Adjunct (e.g., Methylene Blue, Isosulfan Blue), 1 Mg in New York
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in New York
| Provider | Medicare | Services |
|---|---|---|
| Nyeeqasc,llc | $5.94 | 76 |
| Bronx Sc Llc | $6.00 | 30 |
| All City Family Healthcare Center,... | $5.94 | 14 |
New York Pricing in Context
In New York, CPT code Q9968 (Injection, Non-Radioactive, Non-Contrast, Visualization Adjunct (e.g., Methylene Blue, Isosulfan Blue), 1 Mg) carries an average Medicare payment of $5.95 — 9% above the national benchmark of $5.48. 3 providers across the state submitted claims for this procedure in 2023, performing 120 total services. Individual payments in NY ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in New York is $204.25, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because New York sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Temporary Codes procedures, the estimated commercial insurance price in New York lands near $18.64, with self-pay cash prices typically around $61.76. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Injection, Non-Radioactive, Non-Contrast, Visualization Adjunct (e.g., Methylene Blue, Isosulfan Blue), 1 Mg cost in New York?
The average Medicare payment for Injection, Non-Radioactive, Non-Contrast, Visualization Adjunct (e.g., Methylene Blue, Isosulfan Blue), 1 Mg in New York is $5.95, which is 9% above the national average of $5.48. Providers in NY typically bill $204.25 for this procedure.
What does Injection, Non-Radioactive, Non-Contrast, Visualization Adjunct (e.g., Methylene Blue, Isosulfan Blue), 1 Mg cost with insurance in New York?
With commercial insurance in New York, Injection, Non-Radioactive, Non-Contrast, Visualization Adjunct (e.g., Methylene Blue, Isosulfan Blue), 1 Mg costs an estimated $18.64. Without insurance, the estimated cash price is $61.76. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Injection, Non-Radioactive, Non-Contrast, Visualization Adjunct (e.g., Methylene Blue, Isosulfan Blue), 1 Mg in New York?
3 providers in New York billed Medicare for Injection, Non-Radioactive, Non-Contrast, Visualization Adjunct (e.g., Methylene Blue, Isosulfan Blue), 1 Mg in 2023, performing 120 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Injection, Non-Radioactive, Non-Contrast, Visualization Adjunct (e.g., Methylene Blue, Isosulfan Blue), 1 Mg cheaper in New York than the national average?
No — Injection, Non-Radioactive, Non-Contrast, Visualization Adjunct (e.g., Methylene Blue, Isosulfan Blue), 1 Mg costs 9% above the national average in New York. The state average Medicare payment is $5.95 compared to $5.48 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.